Teligent Inc. (TLGT)

4.26 -0.01 (-0.234%)

IEX Real-Time Price

August 17, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 4.27

Price Open 4.28

Volume: 188,226

Avg Volume: 413,730

Market Cap: 228.07M

P/E Ratio -10.14

52 Wk Range 2.43-7.34



TLGT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
48.4M
11.21M
23.87
23.17%

2018-07-13
48.4M
11.33M
13.66
23.41%

2018-06-29
48.4M
11.94M
13.83
24.67%

2018-06-15
48.4M
11.31M
15.19
23.37%




TLGT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-08
Q2 2018
AMC
-0.02 (2)
-0.20
-0.18

2018-05-08
Q1 2018
AMC
-0.04 (2)
-0.05
-0.01

2018-05-01
Q1 2018
N/A
-0.04 (2)
0.00
0.00

2018-03-20
Q4 2017
N/A
-0.13 (1)
0.00
0.00

News

Teligent's (TLGT) CEO Jason Grenfell-Gardner on Q2 2018 Results - Earnings Call Transcript (2018-08-08 21:52 SeekingAlpha)

Teligent, Inc. (TLGT) Q2 2018 Earnings Conference Call August 8, 2018 4:30 PM ET Executives Jason Grenfell-Gardner President and Chief Executive Officer Damian Finio Chief Financial Officer Analysts Elliot Wilbur Raymond James Scott Henry …

 


Statistics

Shares Outstanding: 53.54M

Top 15 Institution Percent: 64.20

Price To Sales: 3.74

Price To Book: 5.83

Revenue: 13.66M

Gross Profit: 3.34M

Cash: 38.23M

Debt: N/A

Return On Assets: -21.21

Return On Equity: -83.30

Profit Margin: -66.54

Price History

Beta: 1.12

50-day Moving Avg: 3.88

200-day Moving Avg: 3.47

YTD Change: 10.65

5-day Change: 2.40

1-month Change: 4.67

3-month Change: 49.47

6-month Change: 40.13

1-year Change: -31.07

Revenue Per Share: 0.00

Revenue Per Employee: 74617.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Teligent Inc.

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.teligent.com

Teligent Inc is a specialty generic pharmaceutical company. It markets and sells generic topical and branded generic injectable pharmaceutical products in the United States and Canada.